It has been determined that levels of SIRT1 increased significantly in hepatocellular carcinoma [18], breast cancer [19], glioblastoma [20], lymphoma [21], and other types of cancer development and invasion [22–25]. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.